TeleHealth

This is the fourth in a series of CEO short interviews about their views on their company, the digital pathology market, lessons learned and perhaps a little insight into their business principles.  My personal thanks to Ms. Shiposh and the...

Mikroscan recently announced news of the appointment of Dr. Martin Stuart as President.  This is a name that should be familiar to many having most recently been with Definiens and Aperio, prior to their acquisition by Leica Biosystems,...

News today courtesy of Philips announcing MGH as a primary site for a clinical validation trial based here in the United States for reproducibility of whole slide imaging (WSI) to glass slides. The PI on the study, Dr. Joe Lennerz has been...

The featured post for today is guest written by Dr. Anil Parwani, known throughout the industry as a key opinion leader and has been very active in digital pathology among many other professional and research interests. In his post he looks...

Results such as these and growth in users of digital pathology with software continue to highlight the digital pathology market landscape that makes a couple of points: The value proposition is about software and continues to highlight the...

Q: What is digital pathology and its inherent value? Simply put, digital pathology is the practice of converting microscopic glass slides into images that can be viewed, managed and analyzed anywhere on the screen. More broadly, digital...